Due to the inherent low atomic number of organic materials, their ability to absorb high-energy rays is relatively weak.

Special Report: Race Oncology has initiated its lead trial site Southside Cancer Care Centre in Miranda, NSW, as the first ...

Race Oncology has been given ethics approval for a Phase I trial of RC220 bisantrene alone and in combination with ...

Those substances included: Benzo(b)fluoranthene, benzo(a)pyrene and benzo(a)anthracene, toxic carcinogens that can cause cancer in humans that are produced by burning organic matter such as coal ...

IN an earlier paper 1 experiments were described which demonstrated hole injection from unexcited and optically excited electrode layers into an adjacent anthracene crystal, resulting in a large ...

Bisantrene is an anthracene-based anticancer drug originally developed by Lederle Laboratories in the 1970s and 1980s. It is known for reduced cardiotoxicity and providing cardioprotection when ...

Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560012, India ...

Division of Organic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Łódź 90-363, Poland The Bio-Med-Chem Doctoral School of the University of ...